David J. Cennimo, professor in the Division of Infectious Diseases at Rutgers New Jersey Medical School, said monkeypox cases are rising across the nation but still low.
The infectious disease doctor mining the microbiome for drugs
In the 2015-16 flu season, more than 145 million doses were distributed by manufacturers, according to the Centers for Disease Control and Prevention, but only 41% of American adults received a vaccine.
Drugmakers renew interest in antibiotic development
Even as Gilead prepares to launch a third hepatitis-C product, drugs offering better antimicrobial resistance are angling for their own moments in the spotlight.